Understanding how BCL10 mutations affect treatment resistance in a type of lymphoma
Overcoming Drug Resistance Driven by BCL10 Mutations in Diffuse Large B Cell Lymphoma
This study is looking at how certain changes in a gene called BCL10 might make it harder for people with diffuse large B cell lymphoma to respond to standard treatments, with the goal of finding better ways to help those patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-10894687 on NIH RePORTER |
What this research studies
This research focuses on diffuse large B cell lymphoma (DLBCL), a common and aggressive form of cancer. It aims to investigate the role of BCL10 mutations in causing resistance to standard treatments, using advanced models to understand how these mutations contribute to cancer progression. By identifying the mechanisms behind this resistance, the research seeks to discover new therapeutic strategies that could improve outcomes for patients with these mutations.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with diffuse large B cell lymphoma, particularly those with identified BCL10 mutations.
Not a fit: Patients with DLBCL who do not have BCL10 mutations may not benefit directly from the findings of this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with DLBCL who have BCL10 mutations, potentially improving their survival rates.
How similar studies have performed: Previous research has shown promising results in targeting mutations in cancer therapies, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Coughlin, Caroline Alice — University of Miami School of Medicine
- Study coordinator: Coughlin, Caroline Alice
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.